Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants (NCT07117669)
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ENP-501 in Non-Peanut Allergic Participants and Participants With a Known Peanut Allergy
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 1/2 study to evaluate the safety and clinical activity of ENP-501 in non-peanut allergic (NPA) healthy participants and participants with an established peanut allergy (PA)
Who can join: Review the eligibility criteria below.
Location: Research Site 001 — Aurora, Colorado
Age range: 14 Years to 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Research Site 001 — Aurora, Colorado
📞 Contact the Study Coordinator
Phone: (661) 322-2206
Email: balraj.sangha@cbcc.global
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peanut Allergy
- Food Oral Immunotherapy for Peanut Allergy — Boston, Massachusetts
- A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy — Little Rock, Arkansas
- Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects — Tucson, Arizona
- Peanut and Tree Nut Desensitization — Toronto, Ontario
- Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy — Montreal, Quebec
- Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety — Montreal, Quebec
Explore by condition: All Peanut Allergy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.